Now private, bluebird bio continues leadership revamp; Roche R&D exec announces retirementnews2025-07-03T11:00:18+00:00July 3rd, 2025|Endpoints News|
Bill Meury brings new perspective to Incyte as Hoppenot retires; Ex-MorphoSys CEO leads revitalized Vor Bionews2025-06-27T11:00:38+00:00June 27th, 2025|Endpoints News|
Roche’s venture arm chief to step down in 2026; AstraZeneca obesity leader has retirednews2025-06-20T11:00:37+00:00June 20th, 2025|Endpoints News|
Bristol Myers gets a key strategist with ‘Team Shibs’; Idorsia to change CEOs after it ‘hit a reset button’news2025-06-13T11:00:07+00:00June 13th, 2025|Endpoints News|
GSK taps Sanofi vet to lead vaccine R&D; Bristol Myers names head of corporate affairsnews2025-06-06T11:00:35+00:00June 6th, 2025|Endpoints News|
Another Bristol Myers exec goes to Acadia; David Southwell takes CEO job at ARCH-backed cancer biotechnews2025-05-30T11:00:14+00:00May 30th, 2025|Endpoints News|
Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca’s Pascal Soriotnews2025-05-23T11:00:05+00:00May 23rd, 2025|Endpoints News|
Novo Nordisk’s global obesity leader is moving on; Flagship biotech gets CEO from Scholar Rocknews2025-05-16T11:00:16+00:00May 16th, 2025|Endpoints News|
Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignmentnews2025-05-09T11:00:38+00:00May 9th, 2025|Endpoints News|
Former Tome CEO joins Flagship startup; NGM Bio chief steps down as restructuring takes effectnews2025-05-02T11:00:17+00:00May 2nd, 2025|Endpoints News|
